Authors: Scrimger, RA Murtha, AD Parliament, MB Venner, PM Hanson, J Houle, G Chetner, M

Citation: Ra. Scrimger et al., Muscle-invasive transitional cell carcinoma of the urinary bladder: A population-based study of patterns of care and prognostic factors, INT J RAD O, 51(1), 2001, pp. 23-30

Authors: Gleave, ME Goldenberg, SL Chin, JL Warner, J Saad, F Klotz, LH Jewett, M Kassabian, V Chetner, M Dupont, C Van Rensselaer, S

Citation: Me. Gleave et al., Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: Biochemical and pathological effects, J UROL, 166(2), 2001, pp. 500-506

Authors: Grover, SA Coupal, L Zowall, H Rajan, R Trachtenberg, J Elhilali, M Chetner, M Goldenberg, L

Citation: Sa. Grover et al., The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model, CAN MED A J, 162(7), 2000, pp. 977-983

Authors: Grover, SA Coupal, L Zowall, H Rajan, R Trachtenberg, J Elhilali, M Chetner, M Goldenberg, L

Citation: Sa. Grover et al., The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model, CAN MED A J, 162(7), 2000, pp. 987-992

Authors: Klotz, LH Goldenberg, SL Jewett, M Barkin, J Chetner, M Fradet, Y Chin, J Laplante, S

Citation: Lh. Klotz et al., CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA results, UROLOGY, 53(4), 1999, pp. 757-763